Pepsinogen testing for evaluation of the success of Helicobacter pylori eradication at 4 weeks after completion of therapy
Background and objective: Pepsinogen levels in plasma are increased by inflammation in the gastric mucosa, including inflammation resulting from Helicobacter pylori infection. A decrease in pepsinogen II level has been suggested as a reliable marker to confirm the successful eradication of infection...
Main Authors: | Marcis Leja, Sanita Lapina, Inese Polaka, Dace Rudzite, Ilona Vilkoite, Ilva Daugule, Anna Belkovets, Sergey Pimanov, Jelena Makarenko, Ivars Tolmanis, Aivars Lejnieks, Viesturs Boka, Ingrida Rumba-Rozenfelde, Uldis Vikmanis |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2014-01-01
|
Series: | Medicina |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1010660X14000020 |
Similar Items
-
Assessment of Serum Pepsinogens with and without Co-Testing with Gastrin-17 in Gastric Cancer Risk Assessment—Results from the GISTAR Pilot Study
by: Claudia Robles, et al.
Published: (2022-07-01) -
Serum gastrin 17, pepsinogen I and pepsinogen II in atrophic gastritis patients living in North-East of Iran
by: Mosalreza Hosseini, et al.
Published: (2013-01-01) -
Factors Associated with False Negative Results in Serum Pepsinogen Testing for Precancerous Gastric Lesions in a European Population in the GISTAR Study
by: Danute Razuka-Ebela, et al.
Published: (2022-05-01) -
Potentialities of a serological method in diagnosis of atrophic gastritis
by: S I Pimanov, et al.
Published: (2008-02-01) -
Association of serum pepsinogens and gastrin-17 with Helicobacter pylori infection assessed by urea breath test
by: Jun-peng Zhou, et al.
Published: (2022-08-01)